ANAPTYSBIO, INC (ANABV)
Investment Snapshot
- Piotroski F-Score 5/9 — moderate financial health
- Loss-making — negative ROE of -257.2%
- Revenue growing at 157% annually
ANAPTYSBIO, INC (ANABV) is a publicly traded company, listed on the NASDAQ . Key value metrics: Piotroski F-Score 5 out of 9 (moderate financial health) .
Value Score
Key Metrics
ANAPTYSBIO, INC — Fundamental Analysis Summary
On financial health, ANABV shows a moderate Piotroski F-Score of 5/9, and negative return on equity of -257.2%.
StockPik's composite Value Score for ANABV is 47/100 — reflecting current market or financial concerns. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
ANABV shows revenue growing at 157% year-over-year, with earnings growing at 91%.